Analysts Expect Addus Homecare Co. (NASDAQ:ADUS) to Post $0.67 Earnings Per Share

Share on StockTwits

Wall Street brokerages expect Addus Homecare Co. (NASDAQ:ADUS) to announce $0.67 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Addus Homecare’s earnings, with the lowest EPS estimate coming in at $0.61 and the highest estimate coming in at $0.71. Addus Homecare reported earnings per share of $0.55 during the same quarter last year, which suggests a positive year over year growth rate of 21.8%. The company is scheduled to report its next quarterly earnings results on Monday, March 2nd.

On average, analysts expect that Addus Homecare will report full year earnings of $2.35 per share for the current fiscal year, with EPS estimates ranging from $2.30 to $2.41. For the next year, analysts anticipate that the company will post earnings of $3.01 per share, with EPS estimates ranging from $2.85 to $3.25. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that follow Addus Homecare.

Addus Homecare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.49 by $0.13. The company had revenue of $169.80 million for the quarter, compared to analyst estimates of $160.25 million. Addus Homecare had a net margin of 3.35% and a return on equity of 8.00%. Addus Homecare’s revenue for the quarter was up 23.3% compared to the same quarter last year.

ADUS has been the topic of a number of recent research reports. Stephens initiated coverage on shares of Addus Homecare in a research note on Monday, October 21st. They set an “overweight” rating and a $97.00 price target on the stock. Oppenheimer set a $91.00 price objective on Addus Homecare and gave the company a “buy” rating in a report on Tuesday, September 17th. William Blair reissued an “outperform” rating on shares of Addus Homecare in a report on Friday, August 9th. Raymond James increased their price target on Addus Homecare from $92.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, November 6th. Finally, Zacks Investment Research downgraded Addus Homecare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 12th. Three equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. Addus Homecare has an average rating of “Buy” and an average price target of $94.00.

In related news, insider W Bradley Bickham sold 7,500 shares of the stock in a transaction on Monday, November 11th. The stock was sold at an average price of $86.83, for a total transaction of $651,225.00. Following the sale, the insider now owns 30,811 shares of the company’s stock, valued at $2,675,319.13. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Brian Poff sold 8,000 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $86.36, for a total value of $690,880.00. Following the sale, the chief financial officer now directly owns 26,241 shares in the company, valued at approximately $2,266,172.76. The disclosure for this sale can be found here. Insiders sold 706,609 shares of company stock valued at $58,400,594 in the last quarter. 20.10% of the stock is currently owned by company insiders.

A number of large investors have recently modified their holdings of ADUS. Marshall Wace North America L.P. acquired a new stake in Addus Homecare in the 1st quarter worth about $34,000. First Trust Advisors LP raised its holdings in shares of Addus Homecare by 1.1% in the 1st quarter. First Trust Advisors LP now owns 18,513 shares of the company’s stock worth $1,177,000 after buying an additional 197 shares in the last quarter. Arizona State Retirement System raised its holdings in shares of Addus Homecare by 1.2% in the 2nd quarter. Arizona State Retirement System now owns 15,746 shares of the company’s stock worth $1,180,000 after buying an additional 188 shares in the last quarter. Aperio Group LLC acquired a new position in shares of Addus Homecare in the 2nd quarter worth approximately $265,000. Finally, Municipal Employees Retirement System of Michigan raised its holdings in shares of Addus Homecare by 431.4% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 15,570 shares of the company’s stock worth $1,167,000 after buying an additional 12,640 shares in the last quarter. 99.75% of the stock is currently owned by hedge funds and other institutional investors.

NASDAQ:ADUS traded down $1.54 on Monday, reaching $91.67. 12,600 shares of the company’s stock were exchanged, compared to its average volume of 177,506. The company has a quick ratio of 5.07, a current ratio of 5.07 and a debt-to-equity ratio of 0.15. The firm has a market capitalization of $1.45 billion, a price-to-earnings ratio of 54.24, a price-to-earnings-growth ratio of 2.93 and a beta of -0.16. The business has a fifty day moving average of $86.36 and a 200-day moving average of $80.02. Addus Homecare has a 52-week low of $57.94 and a 52-week high of $95.35.

Addus Homecare Company Profile

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.

Further Reading: How is a buy-side analyst different from a sell-side analyst?

Get a free copy of the Zacks research report on Addus Homecare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Addus Homecare (NASDAQ:ADUS)

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.